Casdin Capital, LLC Tenaya Therapeutics, Inc. Transaction History
Casdin Capital, LLC
- $1.29 Billion
- Q3 2024
A detailed history of Casdin Capital, LLC transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 6,732,971 shares of TNYA stock, worth $10.1 Million. This represents 1.01% of its overall portfolio holdings.
Number of Shares
6,732,971
Previous 6,732,971
-0.0%
Holding current value
$10.1 Million
Previous $20.9 Million
37.74%
% of portfolio
1.01%
Previous 1.8%
Shares
4 transactions
Others Institutions Holding TNYA
# of Institutions
96Shares Held
56.3MCall Options Held
900Put Options Held
400-
Column Group LLC San Francisco, CA9.4MShares$14.1 Million26.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.98MShares$10.5 Million0.19% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$6.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$4.82 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.03MShares$4.54 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $62M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...